First Quarter 2023 Financial Results
Revenue of $1,257 million, including an estimated $90-$110 million benefit from customer purchasing shifted from the second quarter into the first as a result. | May 9, 2023
Elanco earns USDA approval for parvovirus treatment – Inside INdiana Business insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.
Elanco Animal Health President and CEO Jeff Simmons said the treatment is a potential blockbuster drug, with potential annual sales of more than $100 million.
MELBOURNE, Australia, Sept. 20, 2022 /PRNewswire/ Recent study report released by Data Bridge Market research titled 'Global Veterinary Medicine Market' (covering USA, Europe, China, Japan
/PRNewswire/ Recent study report released by Data Bridge Market research titled Global Veterinary Medicine Market (covering USA, Europe, China, Japan,.